CATEGORIES

Breaking Research

LATEST

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

Pursuing Happy Modernity: AI and Human Exploration in New Research-Based Tech

2024, it will be subject to the qualitative and quantitative changes in artificial intelligence.

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

Readers, including even experts, are falling for a hard sell job by venture capitalists who launder their funding of the study through a nonprofit foundation and seek not legalization